Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

177 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pharmacogenetics of treatments for pancreatic cancer.
El Hassouni B, Li Petri G, Liu DSK, Cascioferro S, Parrino B, Hassan W, Diana P, Ali A, Frampton AE, Giovannetti E. El Hassouni B, et al. Among authors: frampton ae. Expert Opin Drug Metab Toxicol. 2019 Jun;15(6):437-447. doi: 10.1080/17425255.2019.1620731. Epub 2019 May 24. Expert Opin Drug Metab Toxicol. 2019. PMID: 31100206 Review.
The good, the bad and the ugly: a tale of miR-101, miR-21 and miR-155 in pancreatic intraductal papillary mucinous neoplasms.
Caponi S, Funel N, Frampton AE, Mosca F, Santarpia L, Van der Velde AG, Jiao LR, De Lio N, Falcone A, Kazemier G, Meijer GA, Verheul HM, Vasile E, Peters GJ, Boggi U, Giovannetti E. Caponi S, et al. Among authors: frampton ae. Ann Oncol. 2013 Mar;24(3):734-41. doi: 10.1093/annonc/mds513. Epub 2012 Nov 8. Ann Oncol. 2013. PMID: 23139258 Free article.
Role of miRNAs in the response to anticancer therapy.
Frampton AE, Krell J, Giovannetti E, Jiao LR, Stebbing J. Frampton AE, et al. Pharmacogenomics. 2012 Nov;13(15):1663-6. doi: 10.2217/pgs.12.34. Pharmacogenomics. 2012. PMID: 23171328 Free article. No abstract available.
Serum miR-1290 as a marker of pancreatic cancer--letter.
Frampton AE, Krell J, Kazemier G, Giovannetti E. Frampton AE, et al. Clin Cancer Res. 2013 Sep 15;19(18):5250-1. doi: 10.1158/1078-0432.CCR-13-1620. Epub 2013 Jul 25. Clin Cancer Res. 2013. PMID: 23888071 No abstract available.
MicroRNAs cooperatively inhibit a network of tumor suppressor genes to promote pancreatic tumor growth and progression.
Frampton AE, Castellano L, Colombo T, Giovannetti E, Krell J, Jacob J, Pellegrino L, Roca-Alonso L, Funel N, Gall TM, De Giorgio A, Pinho FG, Fulci V, Britton DJ, Ahmad R, Habib NA, Coombes RC, Harding V, Knösel T, Stebbing J, Jiao LR. Frampton AE, et al. Gastroenterology. 2014 Jan;146(1):268-77.e18. doi: 10.1053/j.gastro.2013.10.010. Epub 2013 Oct 9. Gastroenterology. 2014. PMID: 24120476
A microRNA meta-signature for pancreatic ductal adenocarcinoma.
Frampton AE, Giovannetti E, Jamieson NB, Krell J, Gall TM, Stebbing J, Jiao LR, Castellano L. Frampton AE, et al. Expert Rev Mol Diagn. 2014 Apr;14(3):267-71. doi: 10.1586/14737159.2014.893192. Epub 2014 Feb 28. Expert Rev Mol Diagn. 2014. PMID: 24575833
miR-211 modulates gemcitabine activity through downregulation of ribonucleotide reductase and inhibits the invasive behavior of pancreatic cancer cells.
Maftouh M, Avan A, Funel N, Frampton AE, Fiuji H, Pelliccioni S, Castellano L, Galla V, Peters GJ, Giovannetti E. Maftouh M, et al. Among authors: frampton ae. Nucleosides Nucleotides Nucleic Acids. 2014;33(4-6):384-93. doi: 10.1080/15257770.2014.891741. Nucleosides Nucleotides Nucleic Acids. 2014. PMID: 24940696
177 results